Clinical Trial Update: To Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy Adults [Phase 1, Phase 2]

View source ↗

Summary

Pfizer is conducting Phase 1/2 trials to evaluate the safety and effects of a Clostridioides difficile vaccine in healthy adults; the study is currently active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Pfizer Clostridioides difficile vaccine

Snippet

Sponsor: Pfizer | Conditions: Clostridoides Difficile Associated Disease | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING